Lederman Seth

Avg. Two Year Performance

(39%) Avg. Purchase Return
(18%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return5%(8%)(21%)(34%)(39%)
Purchase Success Rate7 of 145 of 145 of 142 of 141 of 14
Average Sale Return----------
Sale Success Rate----------
Drugs » Drug Manufacturers - Major

Chief Executive Officer, Director:

Holdings: 27.75K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--